biomedicina slovenica


pr=Anker : 109

  1. Coats Andrew J.; Heymans Stephane; Farmakis Dimitrios; Anker Stefan D.; Bauersachs Johann; Boer Rudolph A. de; Čelutkienè Jelena; Cleland John G.; Jankowska Eva A.; Lainščak Mitja
    Atrial disease and heart failure
    2022
  2. Cooper Lauren B.; Benson Lina; Mentz Robert J.; Savarese Gianluigi; DeVore Adam D.; Carrero Juan-Jesus; Dahlström Ulf; Anker Stefan D.; Lainščak Mitja; Hernandez Adrian F.
    Association between potassium level and outcomes in heart failure with reduced ejection fraction
    2020
  3. Kapłon-Cieślicka Agnieszka; Benson Lina; Chioncel Ovidiu; Crespo-Leiro Maria G.; Coats Andrew J.; Anker Stefan D.; Filippatos Gerasimos; Ruschitzka Frank; Seferović Petar M.; Lainščak Mitja
    A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry
    2022
  4. Coats Andrew J.; Farmakis Dimitrios; Anker Stefan D.; Baumbach Andreas; Alfieri Ottavio; Filippatos Gerasimos; Bardeleben Stephan von; Bauersachs Johann; Čelutkienè Jelena; Lainščak Mitja
    The management of secondary mitral regurgitation in patients with heart failure
    2021
  5. Rosano Giuseppe M.; Jankowska Eva A.; Ray Robin; Metra Marco; Adamopoulos Stamatis; Anker Stefan D.; Belenkov Yury; Gal Tuvia Ben; Böhm Michael; Lainščak Mitja
    COVID-19 vaccination in patients with heart failure
    2021
  6. Abdin Amr; Anker Stefan D.; Butler Javed; Kindermann Ingrid; Lainščak Mitja; Lund Lars H.; Metra Marco; Mullens Wilfried; Rosano Giuseppe M.; Slawik Jonathan
    'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor
    2021
  7. Kapelios Chris J.; Lainščak Mitja; Savarese Gianluigi; Laroche Cécile; Seferović Petar M.; Ruschitzka Frank; Coats Andrew J.; Anker Stefan D.; Crespo-Leiro Maria G.; Filippatos Gerasimos; Strašek Milena; Savnik-Iskra Mojca; Ravnikar Tinkara; Černič Šuligoj Nataša; Komel Jana; Fras Zlatko; Jug Borut; Glavič Tanja; Lošić Renata; Bombek Mirko; Krajnc Igor; Krunič Barbara; Horvat S.; Kovac Dusan; Rajtman Darko; Cenčič Vid; Letonja Mitja; Winkler Robert; Valentinčič Matej; Melihen Bartolič Cvetka; Bartolić Andrej; Pušnik Maja; Kladnik Majda; Slemenik-Pušnik Cirila; Marolt Apolon; Klen Jasna; Drnovšek Borut; Leskovar Boštjan
    Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry
    2019
  8. Kapelios Chris J.; Laroche Cécile; Crespo-Leiro Maria G.; Anker Stefan D.; Coats Andrew J.; Diaz-Molina Beatria; Filippatos Gerasimos; Lainščak Mitja; Maggioni Aldo P.; McDonagh Theresa A.; Fras Zlatko
    Association between loop diuretic dose changes and outcomes in chronic heart failure
    2020
  9. Shafieesabet Azadeh; Scherbakov Nadja; Ebner Nicole; Sandek Anja; Lokau Stefanie; Haehling Stephan; Anker Stefan D.; Lainščak Mitja; Laufs Ulrich; Doehner Wolfram
    Acute effects of oral triglyceride load on dynamic changes in peripheral endothelial function in heart failure patients with reduced ejection fraction and healthy controls
    2020
  10. Pudil Radek; Mueller Christian; Čelutkienè Jelena; Lenihan Dan; Dent Susan; Barac Ana; Stanway Susanna; Anker Marcus S.; Seferović Petar M.; Lainščak Mitja
    Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies
    2020
  11. Seferović Petar M.; Fragasso Gabriele; Petrie Mark; Mullens Wilfried; Ferrari Roberto; Bauersachs Johann; Anker Stefan D.; Polovina Marija; Metra Marco; Ambrosio Giuseppe; Lainščak Mitja
    Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology
    2020
  12. Anker Marcus S.; Bouleti Claire; Christodoulides Theodoros; Durante Angela; Gara Edit; Milinković Ivan; Nägele Matthias P; Nossikoff Alexander; Lopatin Yuri; Lainščak Mitja
    The heart failure specialists of tomorrow
    2020
  13. Von Haehling Stephan; Valentova Miroslava; Anker Marcus S.; Ebner Nicole; Bekfani Tarek; Haarmann Helge; Schefold Joerg C.; Lainščak Mitja; Cleland John G.; Doehner Wolfram
    Muscle wasting as an independent predictor of survival in patients with chronic heart failure
    2020
  14. Seferović Petar M.; Fragasso Gabriele; Mullens Wilfried; Ferrari Roberto; Bauersachs Johann; Anker Stefan D.; Polovina Marija; Metra Marco; Ambrosio Giuseppe; Lainščak Mitja
    Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure
    2020
  15. Kapłon-Cieślicka Agnieszka; Laroche Cécile; Crespo-Leiro Maria G.; Coats Andrew J.; Anker Stefan D.; Filippatos Gerasimos; Maggioni Aldo P.; Drozdz Jaroslaw; Rosano Giuseppe M.; Lainščak Mitja
    Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry
    2020
  16. Rossignol Patrick; Lainščak Mitja; Crespo Leiro Marisa; Laroche Cécile; Piepoli Massimo Francesco; Filippatos Gerasimos; Rosano Giuseppe M.; Savarese Gianluigi; Anker Stefan D.; Seferović Petar M.; Fras Zlatko
    Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes
    2020
  17. Čelutkienè Jelena; Lainščak Mitja; Gayat Etienne; Grapsa Julia; Harjola Veli-Pekka; Manka Robert; Nihoyannopoulos Petros; Vrettou Rosa; Anker Stefan D.; Filippatos Gerasimos
    Imaging in patients with suspected acute heart failure
    2020
  18. Lainščak Mitja; Milinković Ivan; Polovina Marija; Crespo Leiro Marisa; Lund Lars H.; Anker Stefan D.; Laroche Cécile; Ferrari Roberto; Coats Andrew J.; McDonagh Theresa A.; Fras Zlatko
    Sex- and age-related differences in the management and outcomes of chronic heart failure
    2020
  19. Vitale Christiana; Jankowska Eva A.; Hill Loreena; Piepoli Massimo Francesco; Doehner Wolfram; Anker Stefan D.; Lainščak Mitja; Jaarsma Tiny; Ponikowski Piotr; Rosano Giuseppe M.
    Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure
    2019
  20. Seferović Petar M.; Ponikowski Piotr; Anker Stefan D.; Bauersachs Johann; Chioncel Ovidiu; Cleland John G.; Boer Rudolph A. de; Drexel Heinz; Gal Tuvia Ben; Lainščak Mitja
    Clinical practice update on heart failure 2019
    2019
  21. Lainščak Mitja; Omersa Daniel; Sedlar Nataša; Anker Stefan D.; Farkaš-Lainščak Jerneja
    Heart failure prevalence in the general population
    2019
  22. Everett Brendan M.; Cornel Jan H.; Lainščak Mitja; Anker Stefan D.; Abbate Antonio; Thuren Tom; Libby Peter; Glynn Robert J.; Ridker Paul M.
    Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure
    2019
  23. Rosano Giuseppe M.; Tamargo Juan; Kjeldsen Keld P.; Lainščak Mitja; Agewall Stefan; Anker Stefan D.; Ceconi Claudio; Coats Andrew J.; Filippatos Gerasimos; Kaski Juan Carlos
    Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
    2018
  24. Ameri Pietro; Canepa Marco; Anker Marcus S.; Belenkov Yury; Farmakis Dimitrios; Lainščak Mitja; Seferović Petar M.; Filippatos Gerasimos; Coats Andrew J.; Suter Thomas
    Cancer diagnosis in patients with heart failure
    2018
  25. Seferović Petar M.; Filippatos Gerasimos; Anker Stefan D.; Rosano Giuseppe M.; Bauersachs Johann; Komajda Michel; Cosentino Francesco; Boer Rudolph A. de; Farmakis Dimitrios; Lainščak Mitja
    Type 2 diabetes mellitus and heart failure
    2018
  26. Emami Amir; Saitoh Masakazu; Valentova Miroslava; Sandek Anja; Ebner Nicole; Lončar Goran; Springer Jochen; Doehner Wolfram; Lainščak Mitja; Anker Stefan D.
    Comparison of sarcopenia and cachexia in men with chronic heart failure
    2018
  27. Bekfani Tarek; Pellicori Pierpaolo; Morris Daniel A.; Ebner Nicole; Valentova Miroslava; Sandek Anja; Doehner Wolfram; Cleland John G.; Lainščak Mitja; Anker Stefan D.
    Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life
    2019
  28. Solomon Scott D.; Rizkala Adel R.; Lefkowitz Martin P.; Shi Victor C.; Gong Jian Jian; Anavekar Nagesh; Anker Stefan D.; Arango Juan L.; Arenas Jose L.; Atar Dan; Vrtovec Bojan
    Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial
    2018
  29. Corrà Ugo; Agostoni Pier Giuseppe; Anker Stefan D.; Coats Andrew J.; Crespo-Leiro Maria G.; Boer Rudolph A. de; Harjola Veli-Pekka; Hill Loreena; Lainščak Mitja; Lund Lars H.
    Role of cardiopulmonary exercise testing in clinical stratification in heart failure
    2018
  30. Chioncel Ovidiu; Lainščak Mitja; Seferović Petar M.; Anker Stefan D.; Crespo-Leiro Maria G.; Harjola Veli-Pekka; Parissis John T; Laroche Cécile; Piepoli Massimo Francesco; Fonseca Candida
    Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction
    2017
  31. Ridker Paul M.; Everett Brendan M.; Thuren Tom; MacFadyen Jean G.; Chang William H.; Ballantyne Christie; Fonseca Francisco; Nicolau Jose; Koenig Wolfgang; Anker Stefan D.; Lainščak Mitja
    Antiinflammatory therapy with canakinumab for atherosclerotic disease
    2017
  32. Lainščak Mitja; Anker Stefan D.
    Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges
    2015
  33. Crespo-Leiro Maria G.; Anker Stefan D.; Maggioni Aldo P.; Coats Andrew J.; Filippatos Gerasimos; Ruschitzka Frank; Ferrari Roberto; Piepoli Massimo Francesco; Delgado Jimenez Juan Francisco; Metra Marco; Lainščak Mitja
    European society of cardiology heart failure long-term registry (ESC-HF-LT): 1-year follow-up outcomes and sifferences across regions
    2016
  34. Lončar Goran; Springer Jochen; Anker Marcus S.; Doehner Wolfram; Lainščak Mitja
    Cardiac cachexia: hic et nunc
    2016
  35. Cooper Trond J.; Anker Stefan D.; Comin-Colet Josep; Filippatos Gerasimos; Lainščak Mitja; Lüscher Thomas F.; Mori Claudio; Johnson Patrick; Ponikowski Piotr; Dickstein Kenneth
    Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia
    2016
  36. Lončar Goran; Springer Jochen; Anker Marcus S.; Doehner Wolfram; Lainščak Mitja
    Cardiac cachexia: hic et nunc: Ýhic et nuncÝ - here and now
    2015
  37. Scherbakov Nadja; Bauer Maximiliane; Sandek Anja; Szabo Tibor; Töpper Agnieszka; Jankowska Eva A.; Springer Jochen; Von Haehling Stephan; Anker Stefan D.; Lainščak Mitja; Engeli Stefan; Düngen Hans-Dirk; Doehner Wolfram
    Insulin resistance in heart failure
    2015
  38. McDonagh Theresa A.; Gardner Roy; Lainščak Mitja; Nielsen Olav W.; Parissis John T; Filippatos Gerasimos; Anker Stefan D.
    Heart Failure Association of the European Society of Cardiology specialist heart failure curriculum
    2014
  39. Trobec Katja; Palus Sandra; Tschirner Anika; Von Haehling Stephan; Doehner Wolfram; Lainščak Mitja; Anker Stefan D.; Springer Jochen
    Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia
    2014
  40. Haehling Stephan; Lainščak Mitja; Kung Thomas; Cramer Larissa; Fülster Susan; Pelzer Uwe; Hildebrandt Bert; Sandek Anja; Schefold Joerg C.; Rauchhaus Mathias; Doehner Wolfram; Anker Stefan D.
    Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure
    2013
  41. Ebner Nicole; Springer Jochen; Kalantar-Zadeh Kamyar; Lainščak Mitja; Doehner Wolfram; Anker Stefan D.; Von Haehling Stephan
    Mechanism and novel therapeutic approaches to wasting in chronic disease
    2013
  42. Farkaš-Lainščak Jerneja; Haehling Stephan; Kalantar-Zadeh Kamyar; Morley John E.; Anker Stefan D.; Lainščak Mitja
    Cachexia as a major public health problem
    2013
  43. Lainščak Mitja; Anker Stefan D; von Haehling Stephan
    No train, no gain: Does this apply to heart failure with preserved ejection fraction?
    2013
  44. Lainščak M; Edwards L; Anker S; Crim C; Rennard S; Wouters E; MacNee W
    Clinical impact of anaemia in patients with chronic obstructive pulmonary disease: results from ECLIPSE study
    2012
  45. Comin-Colet J; Lainščak Mitja; Dickstein K; Filippatos GS; Johnson P; Luscher TF; Mori C; Willenheimer R; Ponikowski P; Anker SD
    The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
    2013
  46. Marčun Robert; Sustic Alan; Meško-Brguljan Pika; Kadivec Saša; Farkaš Jerneja; Košnik Mitja; Coats Andrew J; Anker Stefan D; Lainščak Mitja
    Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease
    2012
  47. Lainščak M; von Haehling S; Doehner W; Anker SD
    The obesity paradox in chronic disease: facts and numbers
    2012
  48. Lainščak Mitja; von Haehling Stephan; Doehner Wolfram; Sarc Irena; Jerič Tina; Ziherl Kristina; Košnik Mitja; Anker Stefan D; Šuškovič Stanislav
    Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease
    2011
  49. Goličnik Alenka; Podbregar Matej; Lainščak Mitja; Anker Stefan A; Grubič Zoran; Marš Tomaž
    Atorvastatin modulates constitutive and lipopolysaccharide induced IL-6 secretion in precursors of human skeletal muscle
    2012
  50. Trobec Katja; von Haehling Stephan; Anker Stefan D; Lainščak Mitja
    Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia
    2011
  51. Doehner Wolfram; Todorović Johanna; Kennecke Cornelia; Rauchhaus Mathias; Sandek Anja; Lainščak Mitja; van Linthout Sophie; Tschoepe Carsten; von Haehling Stephan; Anker Stefan D
    Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study
    2012
  52. Gelbrich Goetz; Edelmann Frank; Inkrot Simone; Lainščak Mitja; Apostolović Svetlana; Neskovic Aleksandar; Waagstein Finn; Loeffler Markus; Anker Stefan D; Dietz Rainer
    Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly
    2012
  53. Doehner Wolfram; Haeusler Karl Georg; Endres Matthias; Anker Stefan D; MacNee William; Lainščak Mitja
    Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease
    2011
  54. Cooper TJ; Dickstein K; Hasselberg N; Comin-Colet J; Filippatos G; Lainščak M; Luscher TF; Ponikowski P; Willenheimer R; Anker S
    Changes in symptom and quality-of-life assessments correlate strongly and consistently with changes in functional capacity in patients with heart failure
    2011
  55. Lainščak Mitja; Farkaš Jerneja; Inkrot Simone; Gelbrich Goetz; Nešković Aleksander N; Rau Thomas; Tahirović Elvis; Toepper Agnieszka; Apostolović Svetlana; Haverkamp Wilhelm; Herrmann-Lingen Christoph; Anker Stefan D; Duengen Hans-Dirk
    Self-rated health predicts adverse events during beta-blocker treatment: the CIBIS-ELD randomised trial analysis
    2013
  56. Comin-Colet J; Lainscak M; Dickstein K; Filippatos G; Johnson P; Luscher TF; Mori C; Willenheimer R; Ponikowski P; Anker SD
    Influence of intravenous ferric carboxymaltose on health-related quality of life measures in patients with chronic heart failure and iron deficiency: an analysis from the FAIR-HF study
    2010
  57. Sarc I; Jerič T; Ziherl K; Šuškovič S; Košnik M; Doehner W; Von Haehling S; Anker SD; Lainščak M
    Chronic heart failure in patients hospitalized for chronic obstructive pulmonary disease: prevalence, treatment and mortality
    2010
  58. Lainščak M; Gelbrich G; Inkrot S; Tahirović E; Edelmann F; Doehner W; Nesković A; Apostolović S; Anker SD; Duengen HD
    Beta blockers and pulmonary function in elderly patients with heart failure: insight from CIBIS-ELD
    2010
  59. Sarc Irena; Jerič Tina; Ziherl Kristina; Šuškovič Stanislav; Košnik Mitja; Anker Stefan D; Lainščak Mitja
    Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease
    2011
  60. Šarc Irena; Jerič Tina; Ziherl Kristina; Košnik Mitja; Anker Stefan D; Lainščak Mitja
    Guideline adherence in treatment of COPD
    2010
  61. Rozentryt Piotr; von Haehling Stephan; Lainščak Mitja; Nowak Jolanta U; Lalantar-Zafeh Kamyar; Polonski Lech; Anker Stefan D
    The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study
    2010
  62. Lainščak Mitja; von Haehling Stepan; Anker Stefan D
    Subgroup or selection bias?
    2010
  63. Lainščak Mitja; Majc-Hodošček Lea; von Haehling Stephan; Doehner Wolfram; Anker Stefan D
    The relationship between serum lipids and survival in patients hospitalized with heart failure
    2010
  64. Lainščak M; Gelbrich G; Inkrot S; Tahirović E; Edelmann F; Doehner W; Nešković A; Apostolović S; Anker SD; Duengen H-D
    Pulmonary function during beta-blocker titration in elderly patients with heart failure: the CIBIS-ELD analysis
    2010
  65. Lainščak Mitja; Šarc Irena; Ziherl Kristina; Jerič Tina; Šuškovič Stanislav; Košnik Mitja; von Haehling Stephen; Doehner Wolfram; Anker Stefan D
    Anaemia and survival in patients with chronic obstructive pulmonary disease
    2009
  66. Farkaš J; Lainščak M; Evans WJ; Anker SD
    Cachexia: a public health perspective
    2009
  67. Lainščak Mitja; Anker Markus S; von Haehling Stephan; Anker Stefan D
    Biomarkers for chronic heart failure: diagnostic, prognostic, and therapeutic challenges
    2009
  68. Lainščak Mitja; Duengen Hans-Dirk; Anker Stefan D
    Beta-blockers in elderly patients with heart failure: ready for prime time?
    2009
  69. von Haehling Stephan; Schefold Joerg C; Majc-Hodoscek Lea; Doehner Wolfram; Mannaa Marwan; Anker Stefan D; Lainščak Mitja
    Anaemia is an independent predictor of death in patients hospitalized for acute heart failure
    2009
  70. Szabo Tibor; von Haehling Stephan; Habedank Dirk; Rauchhaus Mathias; Lainščak Mitja; Sandek Anja; Schefold Joerg; Anker Stefan D; Doehner Wolfram
    Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure
    2009
  71. Ziherl K; Šarc I; Jerič T; Košnik M; Šuškovič S; Anker SD; Lainščak M
    Renal Function in Patients with Chronic Obstructive Pulmonary Disease
    2009
  72. Lainščak M; Šarc I; Ziherl K; Jerič T; Košnik M; Šuškovič S; Anker SD
    Atrial Fibrillation and Anticoagulant Therapy in Patients with Chronic Obstructive Pulmonary Disease
    2009
  73. Šarc I; Jerič T; Ziherl K; Košnik M; Šuškovič S; Anker SD; Lainščak M
    Cardiovascular Disease and Cardiovascular Drugs in Patients with Chronic Obstructive Pulmonary Disease: Prevalence and Survival Analysis
    2009
  74. von Haeling Stephan; Lung Thomas; Hodošček-Majc L; schefold Joerg C; Doehner Wolfram; Anker Stefan D; Lainščak Mitja
    Anemia in Patients Hospitalized for Acute Heart Failure
    2009
  75. Lainščak Mitja; von Haehling Stephan; Doehner Wolfram; Šarc Irena; Jerič Tina; Ziherl Kristina; Košnik Mitja; Šuškovič Stanislav; Anker Stefan D
    Chronic Heart Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence, Clinical Characteristics, Treatment and Mortality
    2009
  76. Lainščak M; Hodošček-Majc L; Duengen HD; Doehner W; von Haehling S; Anker SD
    Chronic obstructive pulmonary disease in patients with chronic heart failure: prevalence, clinical characteristics and long-term outcome
    2009
  77. Lainščak M; Hodošček-Majc L; Filippatos GS; Anker SD
    Implementation of guidelines improves mortality in patients admitted in community hospital for decompensated chronic heart failure
    2009
  78. von Haehling Stephan; Schefold Joerg C; Lainščak Mitja; Doehner Wilfram; Anker Stefan D
    Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders
    2009
  79. Lainščak Mitja; Majc-Hodošček Lea; Duengen Hans-Dirk; Rauchhaus Mathias; Doehner Wolfram; Anker Stefan D; von Haehling Stephen
    The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure
    2009
  80. Doehner Wolfram; von Haehling Stephan; Anker Stefan D; Lainščak Mitja
    Neurohormonal activation and inflammation in c hronic cardiopulmonary disease: a brief systematic review
    2009
  81. Lainščak Mitja; Anker Stefan D
    Prognostic factors in chronic heart failure
    2009
  82. Lainščak Mitja; Hodošček-Majc Lea; Majc Dejan; Piotr Rozentryt; Springer Jochen; Doehner Wolfram; von Haehling Stephan; Anker Stefan D
    Liver function markers and mortality in patients with chronic heart failure
    2008
  83. von Haehling Stephan; Lainščak Mitja; Springer Jochen; Anker Stefan D
    Cardiac cachexia: a systematic overview
    2008
  84. Lainščak Mitja; Anker Stefan D; Cleland John G
    Smoking cessation in heart failure: easier said than done
    2009
  85. Lainščak Mitja; von Haehling Stephan; Anker Stefan D
    Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers
    2009
  86. Lainščak Mitja; Sandek Anja; Anker Stefan D
    Cardiac cachexia
    2008
  87. Lainščak Mitja; Doehner Wolfram; Šarc Irena; Jerič Tina; Šuškovič Stanislav; von Haeling Stephan; Košnik Mitja; Fležar Matjaž; Anker Stephan A
    Insulin resistance in non-diabetic patients with chronic obstructive pulmonary disease
    2008
  88. Lainščak Mitja; von Haehling Stephan; Šarc Irena; Ziherl Kristina; Doehner Wolfram; Šuškovič Stanislav; Košnik Mitja; Anker Stefan D
    Anemia predicts survival in patients with chronic obstructive pulmonary disease
    2008
  89. Lainščak M; Hodošček-Majc L; Majc D; Doehner W; Von Haehling S; Anker SD
    Liver function in patients with chronic heart failure
    2008
  90. Doehner W; Von Haehling S; Rauchhaus M; Lainščak M; Habedank D; Sandek A; Szabo T; Anker SD
    Inferiority of single assessment derived estimates of insulin sensitivity for metabolic studies in patients with chronic heart failure
    2008
  91. Doehner W; Karhausen T; Kennecke C; Todorović J; Rauchhaus M; Sandek A; Lainščak M; Von Haehling S; Anker SD
    The impact of irbesartan on impaired insulin sensitivity in chronic heart failure - results from a placebo-controlled, double blinded, randomized proof of concept-trial
    2008
  92. Lainščak M; Hodošček-Majc L; Von Haehling S; Doehner W; Anker SD
    Antithrombotic drugs in patients with chronic heart failure
    2008
  93. Lainščak Mitja; Dagres Nikolas; Filippatos Gerasimos S; Anker Stefan D; Kremastinos Dimitros T
    Atrial fibrillation in chronic non-cardiac disease: where do we stand?
    2008
  94. Lainščak Mitja; Filippatos Gerasimos S; Gheorghiade Mihai; Fonarow Gregg C; Anker Stefan D
    Cachexia: common, deadly, with and urgent need for precise definition and new therapies
    2008
  95. Lainščak M; Anker SD; von Haehling S; Ponikowski P; Libhaber C; Sliwa K
    Pentoxifzlline increases hemoglobin in anemic patients with chronic heart failure
    2007
  96. Lainščak M; Anker SD; von Haehling S; Ponikowski P; Sliwa K
    Pentoxifylline improves the haemoglobin levels in anaemic patients with chronic heart failure
    2007
  97. Farmakis D; Filippatos G; Lainščak M; Parissis JT; Anker SD; Kremastinos DT
    Anticoagulants, antiplatelets, and statins in heart failure
    2008
  98. Haehling SV; Lainščak M; Anker SD
    Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?
    2007
  99. Lainščak Mitja; Podbregar Matej; Anker Stefan D
    How does cachexia influence survival in cancer, heart failure and other chronic diseases?
    2007
  100. Akashi Yoshihiro J; Springer Jochen; Lainščak Mitja; Anker Stefan D
    Atrial natriuretic peptide and related peptides
    2007

1 101  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics